» Articles » PMID: 35621981

The Role of Seawater and Saline Solutions in Treatment of Upper Respiratory Conditions

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2022 May 27
PMID 35621981
Authors
Affiliations
Soon will be listed here.
Abstract

The history of saline nasal irrigation (SNI) is indeed a long one, beginning from the ancient Ayurvedic practices and gaining a foothold in the west at the beginning of the 20th century. Today, there is a growing number of papers covering the effects of SNI, from in vitro studies to randomized clinical trials and literature overviews. Based on the recommendations of most of the European and American professional associations, seawater, alone or in combination with other preparations, has its place in the treatment of numerous conditions of the upper respiratory tract (URT), primarily chronic (rhino)sinusitis, allergic rhinitis, acute URT infections and postoperative recovery. Additionally, taking into account its multiple mechanisms of action and mounting evidence from recent studies, locally applied seawater preparations may have an important role in the prevention of viral and bacterial infections of the URT. In this review we discuss results published in the past years focusing on seawater preparations and their use in clinical and everyday conditions, since such products provide the benefits of additional ions vs. saline, have an excellent safety profile and are recommended by most professional associations in the field of otorhinolaryngology.

Citing Articles

The effect of nasal douching by hypertonic 2.3 per cent sea water with algae extracts on the concentration of epidermal growth factor, transforming growth factor-α and interleukin-8 in nasal secretions of patients with nasal polyposis following....

Peric A, Gacesa D, Kovacevic S, Peric A, Vojvodic D, Georgiou S J Laryngol Otol. 2024; 138(5):520-526.

PMID: 38380493 PMC: 11063653. DOI: 10.1017/S0022215123001974.


Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial.

de Gabory L, Vallet S, Naelten G, Raherison-Semjen C Eur Arch Otorhinolaryngol. 2024; 281(7):3625-3637.

PMID: 38376591 PMC: 11211132. DOI: 10.1007/s00405-024-08518-y.


Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial.

Cegolon L, Mastrangelo G, Emanuelli E, Camerotto R, Spinato G, Frezza D Pharmaceutics. 2022; 14(11).

PMID: 36432693 PMC: 9696981. DOI: 10.3390/pharmaceutics14112502.

References
1.
Taccariello M, Parikh A, Darby Y, Scadding G . Nasal douching as a valuable adjunct in the management of chronic rhinosinusitis. Rhinology. 1999; 37(1):29-32. View

2.
Hildenbrand T, Weber R, Brehmer D . Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature. Eur Arch Otorhinolaryngol. 2010; 268(1):17-26. DOI: 10.1007/s00405-010-1391-z. View

3.
Alvarez-Puebla M, Olaguibel J, Almudevar E, Echegoyen A, Vela C, de Esteban B . Mannitol versus hypertonic saline: Safety and efficacy of mannitol and hypertonic saline in sputum induction and bronchial hyperreactivity assessment. Chron Respir Dis. 2015; 12(3):197-203. DOI: 10.1177/1479972315576144. View

4.
Rapiejko P, Jurkiewicz D . [The use of hypertonic sea-water solution in patients after surgery of the nose and paranasal sinuses]. Otolaryngol Pol. 2010; 64(1):20-30. DOI: 10.1016/S0030-6657(10)70031-7. View

5.
Tano L, Tano K . A daily nasal spray with saline prevents symptoms of rhinitis. Acta Otolaryngol. 2004; 124(9):1059-62. DOI: 10.1080/00016480410017657. View